Mr. Chair, Health Canada first received reports last spring—in April—concerning some issues in some provinces, like Ontario and Newfoundland, for example. We sought further information and engaged the range of stakeholders, including the manufacturers and market authorization holders.
Certainly, from that part onwards, we engaged a group of stakeholders and made clear the opportunity to augment supply through the importation of foreign product.